Miami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Fifth Annual - Day 2

MIami, FL US
March 9, 2024

Live Symposium | 11.25 Cat. 1
Friday-Saturday, March 8-9, 2024
JW Marriott Miami, Miami, FL

Given the increasing frequency of hematologic malignancies and the  complexities of treatments with novel agents, particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic  treatment options.


Course Summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 General certificate of attendance
  • 4.20 Florida Board of Laboratory Personnel
  • 4.00 Nurse Practitioners
  • 4.00 Florida Board of Nursing
  • 4.25 Florida Board of Pharmacy
  • 4.00 Florida Board of Respiratory Therapy
Course opens: 
Course expires: 
Event starts: 
03/09/2024 - 8:00am EST
Event ends: 
03/09/2024 - 1:15pm EST


Friday, March 8

7:30 - 8:00 a.m. Product Theater
8:00 - 8:30 a.m.Registration and Breakfast
8:30 - 8:45 a.m. Welcome and Introductions
Guenther Koehne, M.D., Ph.D. 
Acute Myeloid Leukemia
8:45 – 9:15 a.m. Acute Myeloid Leukemia in 2024
Richard Stone, M.D.
9:15 – 9:45 a.m.Targeted Therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
Novel Approaches to Leukemia Therapies
9:45 – 10:15 a.m. LYT-200, an Anti-Galectin-9 Antibody in Clinical Development for AML/High-risk MDS
Aleksandra Filipovic M.D. Ph.D.
10:15 – 10:45 a.m.Immunotherapeutic Approaches to Undruggable Leukemia Targets
David Scheinberg M.D., Ph.D.
10:45 – 11:15 a.m. Break and Exhibits
11:15 – 11:45 a.m. CD34+-selected Allografts as Platform for Post-Transplant CAR T-Cell Therapy in AML
Guenther Koehne, M.D., Ph.D.
11:45 – 12:15 p.m.The Role of Haploidentical Transplants in 2024
Leo Luznik, M.D.
12:15 – 12:45 p.m.Myelofibrosis: Current and Emerging Treatments
Raajit Rampal, M.D.
12:45 – 1:15 p.m.Lunch and Exhibits 
1:15 – 1:45 p.m.Product Theater
Multiple Myeloma
1:45 – 2:15 p.m.The Role of Auto SCT for Multiple Myeloma in 2024
Saad Usmani, M.D.
2:15 – 2:45 p.m.Targeted Therapies for Multiple Myeloma in 2024
Adam Cohen, M.D.
2:45 – 3:15 p.m. Optimizing the Management of Relapsed and Refractory Multiple Myeloma in the Era of Immunotherapy
Paul Richardson, M.D.
3:15 – 3:45 p.m. Galectin-9 as a Therapeutic Primer to Boost Anti-SLAM7 Efficacy in Multiple Myeloma
Charles Dimitroff, Ph.D.
3:45 – 4:15p.m. Break and Exhibits
Special Presentations
4:15 – 4:45 p.m. Overview of Cellular and Immunotherapies in South America: Current Status and Unmet Needs
Patricio Duarte, M.D.
4:45 – 5:15 p.m.Questions & Answers
5:15 p.m.Adjourn

Saturday, March 9

7:30 – 8:00 a.m. Product Theater
8:00 – 8:30 a.m. Registration and Breakfast 
CAR T-Cell Therapies 
8:30 – 9:00 a.m. Next Steps in CAR T-Cell Therapies
Michel Sadelain, M.D., Ph.D.
9:00 – 9:30 a.m.Do We Need a CAR T-Cell Registry?
Marcelo Pasquini, M.D.
9:30 – 10:00 a.m.The Role of Intestinal Microbiome in Cancer Immunotherapy
Marcel van den Brink, M.D., Ph.D.
Acute Leukemia 
10:00 – 10:30 a.m.Developing Next Generation T-Cell Therapies for AML
Catherine Bollard, M.D.
10:30 – 11:00 a.m.Break and Exhibits
11:00 – 11:30 a.m. Taking the Next Steps to Improving Outcomes in ALL
Wendy Stock, M.D.
11:30 – 12:00 p.m. The Role of Allogeneic Hematopoietic Stem Cell Transplantation for ALL in 2024
Robert Soiffer, M.D.
Non-Hodgkin Lymphoma   
12:00 – 12:30 p.m. Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)
Matthew Matasar, M.D.
12:30– 1:00 p.m. CAR T-Cell Therapies for NHL
Craig Sauter, M.D.
1:00 – 1:15 p.m.Questions & Answers
1:15 p.m. Adjourn

NOTE: Schedule subject to change.

JW Marriott
1109 Brickell Avenue
MIami, FL 33131
United States


JW Marriott Miami

1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500

About the Venue

The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.

Rooms Rates and Highlights

  • Special group rates starting from $379 USD per night, plus taxes/fees
  • 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center

Travel Information

The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.

Services + Amenities

Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.

Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.


With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.

La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.

Downtown Miami and Brickell

Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.

Explore Downtown Miami and BrickellExplore Miami

COVID-19 Protocols for All Attendees, Exhibitors and Vendors

Proof of COVID-19 vaccination or negative COVID-19 test is no longer required to attend a Baptist Health CME conference or symposium.

Baptist Health's in-person COVID-19 policy is subject to change based on COVID-19 community levels and any updated guidance from CDC and/or federal or state officials in localities hosting a Baptist Health in-person meeting or event. Baptist Health reserves the right to modify its COVID-19 related procedures and health screening protocols in its sole discretion at any time. Participants will be informed of any such changes on an ongoing basis.

Masks are welcome but not required. Please understand and respect that wearing a mask is a personal and individual choice of your fellow conference attendees.  Masks will made available for attendees onsite at conferences upon request.

Symposium Director

Guenther Koehne, M.D., Ph.D.
Deputy Director
Chief, Blood and Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida


Catherine Bollard, M.D.
Director, Center for Cancer and Immunology
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Interim Chair, Department of Pediatrics
Interim Director, Children's National Research Institute
Interim Executive Vice President & Chief Academic Officer
Children's National Hospital
Washington, D.C.
Adam Cohen, M.D.
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Charles Dimitroff, Ph.D.
Executive Associate Dean for Research
Director, Translational Glycobiology Institute
Professor, Department of Translational Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Patricio Duarte, M.D.
Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina
Aleksandra Filipovic, M.D., Ph.D.
Department of Surgery and Cancer
Imperial College of London
London, England
Leo Luznik, M.D.
Professor of Oncology
Johns Hopkins Medicine
Baltimore, Maryland
Matthew Matasar, M.D.
Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Marcelo Pasquini, M.D.
Medical Oncologist
Medical College of Wisconsin
Milwaukee, Wisconsin
Raajit Rampal, M.D.
Associate Member
Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
Paul G. Richardson, M.D.
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Michel Sadelain, M.D., Ph.D.
Center for Cell Engineering
Memorial Sloan Kettering Cancer Center
New York, New York
Craig Sauter, M.D.
Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio
David Scheinberg, M.D., Ph.D.
Director, Experimental Therapeutics Center
Deputy Director, SKI for Therapeutic Discovery
Memorial Sloan Kettering Cancer Center
New York, New York 
Robert Soiffer, M.D.
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Eytan Stein, M.D.
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Wendy Stock, M.D.
Anjuli Seth Nayak Professor of Leukemia Research
Section of Hematology/Oncology
University of Chicago Medicine and Comprehensive Cancer Center
Chicago, Illinois
Richard Stone M.D.
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Saad Usmani, M.D., MBA, FACP
Chief of Myeloma Service Chief
Attending Physician, Myeloma, Cellular Therapy and Adult BMT
Memorial Sloan Kettering Cancer Center
New York, NY
Marcel van den Brink, M.D., Ph.D.
Medical Oncologist
Head, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

NOTE: Faculty subject to change.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a total of 11.25 credit hours. Day 1 - 7 hours CE Broker Course #20-1177474, Day 2 - 4.25 hours CE Broker Course #20-1177480, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 11.0 credit hours for Nurse Practitioners, Nurses, Laboratory Personnel and Respiratory Therapists. Day 1 - 7 hours CE Broker Course #20-1177474, Day 2 - 4. hours CE Broker Course #20-1177480, Baptist Health South Florida CE Broker Provider #50-182.

This activity has also been approved for 11.25 for Pharmacists and Techs. Day 1 - 7 hours CE Broker Course #20-1177474, Day 2 - 4.25 hours CE Broker Course #20-1177480, Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
  • 4.25 General certificate of attendance
  • 4.20 Florida Board of Laboratory Personnel
  • 4.00 Nurse Practitioners
  • 4.00 Florida Board of Nursing
  • 4.25 Florida Board of Pharmacy
  • 4.00 Florida Board of Respiratory Therapy
By selecting any of the links below, you are leaving the Baptist Health website.

We gratefully acknowledge the following exhibitors:



Adaptive Biotechnologies

ADC Therapeutics

Agios Pharmaceuticals

Amgen Oncology Rare Disease

Astellas Oncology



Blueprint Medicines

Bristol-Myers Squibb

CTI Biopharma

Daiichi Sankyo

Florida Society of Clinical Oncology (FLASCO)




Janssen Oncology

Jazz Pharmaceuticals

Karyopharm Therapeutics

Kite Pharma

Lilly Oncology


Miami Cancer Institute


Novartis Pharmaceuticals

Omeros Corporation

Pfizer Oncology

Pharmacosmos Therapeutics

PureTech Health

Recordati Rare Diseases

Rigel Pharmaceuticals

Sanofi Genzyme


Sanofi Rare Disorders 

Sanofi Rare Blood Disorders-Specialty Care.  


Stemline Therapeutics

Taiho Oncology

Takeda Oncology

We welcome the following companies as first-time exhibitors:

Bioline RX


Ipsen Biopharmaceuticals

Kyowa Kirin

Notable Labs


Please login or register for a Baptist Health CME account to take this course.